Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Fentanyl vs Oral Morphine for Pediatric Traumatic Pain (FINDOL)
NCT03063359Phase 3Terminated
- Sponsor
- CHU Montpellier
- Start
- May 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in acute pain, sponsored by CHU Montpellier. Started May 2017; status: terminated.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03063359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063359.